Show simple item record

dc.contributor.authorHinderaker, Sven Gudmundeng
dc.contributor.authorMadland, Simoneng
dc.contributor.authorUllenes, Martineng
dc.contributor.authorEnarson, Donald Arthuseng
dc.contributor.authorRusen, I. D.eng
dc.contributor.authorKamara, Deudatuseng
dc.date.accessioned2012-01-20T15:23:43Z
dc.date.available2012-01-20T15:23:43Z
dc.date.issued2011-05-12eng
dc.identifier.citationBMC Public Health 2011, 11:306en
dc.identifier.issn1471-2458eng
dc.identifier.urihttp://hdl.handle.net/1956/5485
dc.description.abstractBackground: Several FIDELIS projects (Fund for Innovative DOTS Expansion through Local Initiatives to Stop TB) in Tanzania were conducted by the National Tuberculosis and Leprosy Programme (NTLP) during the years 2004-2008 to strengthen diagnostic and treatment services. These projects collected information on treatment delay and some of it was available for research purposes. With this database our objective was to assess the duration and determinants of treatment delay among new smear positive pulmonary tuberculosis (TB) patients in FIDELIS projects, and to compare delay according to provider visited prior to diagnosis. Methods: Treatment delay among new smear positive TB patients was recorded for each patient at treatment initiation and this information was available and fairly complete in 6 out of 57 districts with FIDELIS projects enrolling patients between 2004 and 2007; other districts had discarded their forms at the time of analysis. It was analysed as a cross sectional study. Results: We included 1161 cases, 10% of all patients recruited in the FIDELIS projects in Tanzania. Median delay was 12 weeks. The median duration of cough, weight loss and haemoptysis was 12, 8 and 3 weeks, respectively. Compared to Hai district Handeni had patients with longer delays and Mbozi had patients with shorter delays. Urban and rural patients reported similar delays. Patients aged 15-24 years and patients of 65 years or older had longer delays. Patients reporting contact with traditional healers before diagnosis had a median delay of 15 weeks compared to 12 weeks among those who did not. Patients with dyspnoea and with diarrhoea had longer delays. Conclusion: In this patient sample in Tanzania half of the new smear positive pulmonary tuberculosis patients had a treatment delay longer than 12 weeks. Delay was similar in men and women and among urban and rural patients, but longer in the young and older age groups. Patients using traditional healers had a 25% longer median delayen
dc.language.isoengeng
dc.publisherBioMed Centraleng
dc.rightsAttribution CC BYeng
dc.rights.urihttp://creativecommons.org/licenses/by/2.0/eng
dc.titleTreatment delay among tuberculosis patients in Tanzania: Data from the FIDELIS Initiativeeng
dc.typePeer reviewedeng
dc.typeJournal articleeng
dc.subject.nsiVDP::Medical disciplines: 700::Health sciences: 800::Community medicine, Social medicine: 801eng
dc.subject.nsiVDP::Medical disciplines: 700::Health sciences: 800::Health service and health administration research: 806eng
dc.rights.holderCopyright 2011 Hinderaker et al; licensee BioMed Central Ltd.
dc.type.versionpublishedVersioneng
bora.peerreviewedPeer reviewedeng
bibo.doihttp://dx.doi.org/10.1186/1471-2458-11-306eng
dc.identifier.cristinID845453eng
dc.identifier.doi10.1186/1471-2458-11-306


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution CC BY
Except where otherwise noted, this item's license is described as Attribution CC BY